IRIS
RAVERA, Mauro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.424
NA - Nord America 5.808
AS - Asia 3.720
SA - Sud America 688
AF - Africa 133
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 7
Totale 16.790
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.644
RU - Federazione Russa 1.694
IE - Irlanda 1.387
SG - Singapore 1.097
CN - Cina 980
DE - Germania 841
SE - Svezia 691
HK - Hong Kong 589
UA - Ucraina 547
VN - Vietnam 535
BR - Brasile 528
IT - Italia 371
FI - Finlandia 352
FR - Francia 245
IN - India 162
GB - Regno Unito 120
CA - Canada 105
AR - Argentina 63
KR - Corea 59
BD - Bangladesh 44
MX - Messico 43
ID - Indonesia 41
BJ - Benin 40
ZA - Sudafrica 39
IR - Iran 37
PL - Polonia 37
EC - Ecuador 32
TR - Turchia 31
ES - Italia 26
JP - Giappone 26
BE - Belgio 23
AT - Austria 18
IQ - Iraq 18
PK - Pakistan 18
CO - Colombia 17
NL - Olanda 17
CL - Cile 16
LT - Lituania 15
UZ - Uzbekistan 15
EG - Egitto 14
VE - Venezuela 13
MA - Marocco 11
RO - Romania 11
EU - Europa 10
SA - Arabia Saudita 10
PY - Paraguay 9
JO - Giordania 8
TN - Tunisia 7
AL - Albania 6
AU - Australia 6
NP - Nepal 6
AE - Emirati Arabi Uniti 5
HR - Croazia 5
IL - Israele 5
TH - Thailandia 5
UY - Uruguay 5
AZ - Azerbaigian 4
KE - Kenya 4
PA - Panama 4
PH - Filippine 4
CH - Svizzera 3
CI - Costa d'Avorio 3
ET - Etiopia 3
NG - Nigeria 3
OM - Oman 3
PE - Perù 3
PS - Palestinian Territory 3
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
CG - Congo 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
HN - Honduras 2
HU - Ungheria 2
KZ - Kazakistan 2
PT - Portogallo 2
RS - Serbia 2
SI - Slovenia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
AM - Armenia 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CM - Camerun 1
DM - Dominica 1
DZ - Algeria 1
GD - Grenada 1
GY - Guiana 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
ML - Mali 1
MY - Malesia 1
NI - Nicaragua 1
Totale 16.783
Salva come PNG Salva come JPEG
Città #
Dublin 1.379
Jacksonville 991
Hong Kong 586
Dearborn 542
Singapore 458
San Jose 424
Ashburn 367
Beijing 304
Chandler 253
Wilmington 237
New York 223
Moscow 218
Lauterbourg 176
Ho Chi Minh City 173
Lawrence 173
Princeton 173
Los Angeles 171
Ann Arbor 160
San Mateo 128
Hanoi 114
Andover 108
Piemonte 104
Buffalo 91
Munich 80
São Paulo 61
Toronto 57
Seoul 54
Grafing 48
Orem 46
Bremen 43
Dallas 42
Santa Clara 42
Novara 41
Cotonou 40
Frankfurt am Main 37
Redondo Beach 37
Helsinki 33
Hefei 32
Denver 31
Nanjing 30
Montreal 28
Houston 27
Warsaw 27
Chennai 26
Da Nang 25
Woodbridge 25
Guangzhou 24
Atlanta 23
Kunming 23
Tokyo 23
Haiphong 22
Monmouth Junction 22
Boardman 21
Norwalk 21
Stockholm 21
Brussels 20
Leawood 20
Cave Creek 19
Hangzhou 19
Johannesburg 19
London 19
Mexico City 19
Brooklyn 18
Chicago 18
Rio de Janeiro 18
Biên Hòa 16
Mumbai 16
Nuremberg 16
Zanjan 16
Manchester 15
Tashkent 15
Tianjin 15
Poplar 14
Fairfield 13
Milan 13
Ardabil 12
Belo Horizonte 12
Hải Dương 12
Turin 12
Ankara 11
Augusta 11
Brasília 11
Jinan 11
Kocaeli 11
Quito 11
Shanghai 11
Turku 11
Amsterdam 10
Boston 10
Guayaquil 10
Hebei 10
Jakarta 10
Ninh Bình 10
Seattle 10
Wuhan 10
Campinas 9
Council Bluffs 9
Shenyang 9
Thái Bình 9
Vienna 9
Totale 9.264
Salva come PNG Salva come JPEG
Nome #
Antiproliferative Activity of Pt(IV) Conjugates Containing the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Ketoprofen and Naproxen 160
Cisplatin and valproate released from the bifunctional [Pt(IV)Cl2(NH3)2(valproato)2] antitumor prodrug or from liposome formulations: who does what? 154
Antiproliferative activity of Pt(IV)-bis(carboxylato) conjugates on malignant pleural mesothelioma cells 149
Antiproliferative activity of a series of cisplatin-based Pt(IV)-acetylamido/carboxylato prodrugs 142
Transition metal carbonyl clusters in biology: A futile or niche research area? 142
Antiproliferative Pt(IV) complexes: synthesis, biological activity, and quantitative structure-activity relationship modeling 140
Antiproliferative Activity of PtII Complexes with Carboxylated Phosphanes in Chelated or Ring-Opened Forms 135
Beyond the Pt(II)-based chemotherapy: Pt(IV) complexes as oral anticancer pro-drugs 134
The antiproliferative activity of dicobalt-hexacarbonyl-aspirin complex on different malignant pleural mesotelioma phenotypes 133
Assessment of the anticancer potentiality of a new platinum nanoparticulate coniugate 133
A different way for the oxidation of the Pt(II) complexes 131
A New Entry to Asymmetric Platinum(IV) Complexes via Oxidative Chlorination 130
Functional fluorescent nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs 129
Different strategies to exploit Pt(IV) complexes as pro-drugs 128
Functionalized nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs 128
Cellular trafficking, accumulation and DNA platination of a series of cisplatin-based dicarboxylato Pt(IV) prodrugs 127
Hybrid inorganic (nonporous silica)/organic (alginate) core-shell platform for targeting a cisplatin-based Pt(IV) anticancer prodrug 127
A step towards development of promising trypanocidal agents: Synthesis, characterization and in vitro biological evaluation of ferrocenyl Mannich base-type derivatives 126
Appraisal of the Redox Behaviour of the Antimetastatic Ruthenium(III) Complex [ImH][RuCl4(DMSO)(Im)], NAMI-A 124
Biological activity of a series of cisplatin-based aliphatic bis(carboxylato) Pt(IV) prodrugs: How long the organic chain should be? 123
The cisplatin-based Pt(IV)-diclorofibrato multi-action anticancer prodrug exhibits excellent performances also under hypoxic conditions 123
Moving the paradigm in platinum-based chemotherapy from Pt(II) to Pt(IV) complexes? 122
Application of microwave-assisted heating to the synthesis of Pt(II) complexes 121
Cis,cis,trans-[PtIVCl2(NH3)2(perillato)2], a dual-action prodrug with excellent cytotoxic and antimetastatic activity 121
Estradiol as Carrier For Selective Delivery of Cytotoxic Pt(II) Complexes to Cancer Cell Nuclei 120
Study of the synthesis, antiproliferative properties, and interaction with DNA and polynucleotides of cisplatin-like Pt(II) complexes containing carcinogenic polyaromatic amines 120
Host-guest inclusion systems of Pt(IV)-bis(benzoato) anticancer drug candidates and cyclodextrins 120
Pt(IV) Bifunctional Prodrug Containing 2-(2-Propynyl)octanoato Axial Ligand: Induction of Immunogenic Cell Death on Colon Cancer 120
Experimental (RP-HPLC) and theoretical (MIFs) study of the lipophilicity of a series of Pt(IV) complexes 119
Cytotoxicity of some Pt(II)-diamine complexes: a QSAR evaluation of the effect of chelating arms and leaving groups 119
Antitumor platinum(IV) pro-drugs: synthesis, characterization, cytotoxicity and QSAR analysis 117
An unsymmetric cisplatin-based Pt(IV) derivative containing 2-(2-propynyl)octanoate: A very efficient multi-action antitumor prodrug candidate 117
Experimental and molecular modeling approaches to determine the lipophilicity of a Pt(IV) pro-drugs 116
A view on multi-action Pt(IV) antitumor prodrugs 116
May glutamine addiction drive the delivery of antitumor cisplatin-based Pt(IV) prodrugs? 115
How to obtain Pt(IV) complexes suitable for conjugation to nanovectors from the oxidation of [PtCl(terpyridine)]+ 115
Polyanionic Biopolymers for the Delivery of Pt(II) Cationic Antiproliferative Complexes 113
New Platinum-Based Prodrug Pt(IV)Ac-POA: Antitumour Effects in Rat C6 Glioblastoma Cells 113
Effects of dimethylsulfoxide and ethanol on the cytotoxic activity of titanocene dichloride 112
Application of the anthraquinone drug rhein as an axial ligand in bifunctional Pt(iv) complexes to obtain antiproliferative agents against human glioblastoma cells 111
Pros and cons of bifunctional platinum drugs: two are (not always) better than one 111
Bifunctional Pt-ethacrynic acid conjugates for malignant mesothelioma 110
Evaluation of Platinum–Ethacrynic Acid Conjugates in the Treatment of Mesothelioma 110
Electrochemical measurements confirm the preferential bonding of the antimetastatic complex [ImH][RuCl(4)(DMSO)(Im)] (NAMI-A) with proteins and the weak interaction with nucleobases 109
Solvolysis of a Series of Cisplatin-Like Complexes – Comparison between DNA-Biosensor and Conductivity Data 109
Anthracene-terpyridine metal complexes as new G-quadruplex DNA binders 108
Synthesis, characterization and antiproliferative activity on mesothelioma cell lines of bis(carboxylato)platinum(IV) complexes based on picoplatin 107
Classical Pt(II) anticancer complexes revised in view of drug targeting and delivery 106
Synthesis and characterization of cyclohexane-1R,2R-diamine-based Pt(iv) dicarboxylato anticancer prodrugs: their selective activity against human colon cancer cell lines 106
Freshening up Old Methods for New Students: A Colorful Laboratory Experiment to Measure the Formation Constants of Ni(II) Complexes Containing Ethane-1,2-Diamine 106
Synthesis, characterization and antiproliferative activity of platinum(IV) derivates of picoplatin 105
An experiment in the electrokinetic removal of copper from soil contaminated by the brass industry 104
Oxidative degradation of 1,5-naphthalenedisulfonic acid (NDS) in aqueous solutions by microwave irradiation in the presence of H2O2 104
Two are (not always) better than one: the case of bifunctional platinum(IV) drugs 104
Synthesis of PtIV-Biomolecule Conjugates through Click Chemistry 104
Electronic Communication in [Co2(CO)6]2-diyne and [Co2(CO)4(dppm)]2-diyne Complexes 102
Pt(IV) – histone deacetylase inhibitor conjugates for citotoxicity studies on MPM cells 99
The hexacarbonyldicobalt derivative of aspirin acts as a CO-releasing NSAID on malignant mesothelioma cells 99
Prediction of logP for Pt(II) and Pt(IV) complexes: Comparison of statistical and quantum-chemistry based approaches 99
Can the Self-Assembling of Dicarboxylate Pt(IV) Prodrugs Influence Their Cell Uptake? 99
A comparative study of the effects of platinum(II) complexes on β-amyloid aggregation: Potential neurodrug applications 99
Bioinorganic chemistry: the study of the fate of platinum-based antitumour drugs 98
Pt(IV) complexes as anticancer prodrugs 98
Unprecedented one-pot synthesis of an unsymmetrical cisplatin-based Pt(IV)-acetamidato complex 98
Metallo-drugs in the Treatment of Malignant Pleural Mesothelioma 97
Pt(IV)/Re(I) Chitosan Conjugates as a Flexible Platform for the Transport of Therapeutic and/or Diagnostic Anticancer Agents 97
Oxidative degradation of 1,5-naphthalenedisulfonic acid in aqueous solutions by UV-photolysis in the absence and presence of H2O2 95
Molecular Interaction Fields vs. Quantum-Mechanical-based descriptors in the modelling of lipophilicity of platinum(IV) complexes 95
Pt(iv) complexes based on cyclohexanediamines and the histone deacetylase inhibitor 2-(2-propynyl)octanoic acid: synthesis, characterization, cell penetration properties and antitumor activity 95
Electrochemical Behavior of the Electronically and Coordinatively Unsaturated [Os3(µ-H)(CO)8{Ph2PCH2P(Ph)C6H4}] Cluster 94
Solvolysis of Cisplatin and N-Methylated cis-[PtCl2(en)] Complexes – Comparison between DNA-Biosensor and Conductivity Data 93
Pyrazolyl-diamine Pt(II) complexes bearing DNA-intercalating moieties: Synthesis, characterization and in vitro evaluation 93
Bifunctional Ethacrynic Acid – Pt Conjugates: In vitro Treatment of Malignant Pleural Mesothelioma 93
Inhibition of telomerase activity by platinum derivatives 92
Electrochemical Biosensor Assay of the Interaction between [PtCl(n)(NH(3))(4-n)]((2-n)) (n=0-4) Complexes and ds-DNA 91
Bidentate and tridentate pyrazolyl-containing Pt(II) complexes: synthesis, characterization and in vitro evaluation 90
Molecular and statistical modeling of reduction peak potential and lipophilicity of platinum(IV) complexes 90
Conjugation between maleimide-containing Pt(IV) prodrugs and furan or furan-containing drug delivery vectors via Diels-Alder cycloaddition 89
Electron Interactions in Cluster Dimers. An Electrochemical Approach 88
Synthesis and in-vitro cytotoxicity of cis,cis,trans-diammine dichlorido disuccinatoplatinum(IV)-peptide bioconjugates 88
Revisiting [PtCl2(cis-1,4-DACH)]: An Underestimated Antitumor Drug with Potential Application to the Treatment of Oxaliplatin-Refractory Colorectal Cancer 88
Unsymmetric cisplatin-based pt(Iv) conjugates containing a parp-1 inhibitor pharmacophore tested on malignant pleural mesothelioma cell lines 88
Pt(II) complexes with bidentate and tridentate pyrazolyl-containing chelators: synthesis, structural characterization and biological studies 87
Electron Interactions in Cluster Diynes. An Electrochemical Approach 84
Experimental determination and modeling of the lipophilicity in platinum complexes 84
trans,cis,cis-Bis(benzoato)dichlorido(cyclohexane-1R,2R-diamine)platinum(IV): a Prodrug Candidate for the Treatment of Oxaliplatin-Refractory Colorectal Cancer 84
Over 100 Years of Research on Cyclopentadienylironcarbonyl Chemistry: Microscale-Integrated Organometallic Experiments 83
The Stepwise Reduction of Dinitrogen Occurring on a Divanadium Model Compound: A Synthetic, Structural, Magnetic, Electrochemical and Theoretical Investigation on the [V=N=N=V]n+ [n = 4, 5, 6] Based Complexes 83
Stabilization of carbenium ions derived from ethynylestradiol by different adjacent organometallic moieties. Implication in the inactivation of the estrogen receptor 83
Electrochemical, Theoretical and Structural Investigations on the "Butterfly" Co4(CO)8L2(RC2R) (L=CO, PPh3, R=H, Et, Ph) Cluster 82
The interaction between platinum(II) antiproliferative drugs and DNA evaluated by means of an electrochemical biosensor 82
Targeting and delivery of Pt(II) antiproliferative drugs 81
Studies on Log Po/w of Quinoxaline di-N-Oxides: A Comparison of RP-HPLC Experimental and Predictive Approaches 81
The activation of platinum(II) antiproliferative drugs in carbonate medium evaluated by means of a DNA-biosensor 81
Ethynylestradiol-Pt(II) complexes for selective drug targeting 80
Estrogenic carriers for cytotoxic Pt(II) complexes: light and shade 80
The Microscale Synthesis and Electrochemistry of Low-Valent Mononuclear Complexes (h3-C3H5)Fe(CO)3X (X = I, Br, Cl) 80
Poly(methylmetacrylate) (PMMA) core-shell nanospheres act as efficient pharmacophores for the antiproliferative [PtCl3(NH3)]- complex by forming ionic couples 79
Functionalized thymidine derivatives as carriers for the γ-emitter technetium tricarbonyl moiety 79
Pt(iv) antitumor prodrugs: dogmas, paradigms, and realities 79
Totale 10.667
Salva come PNG Salva come JPEG
Categoria #
all - tutte 84.113
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.113
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021256 0 0 0 0 0 0 0 0 0 47 186 23
2021/20221.220 69 20 171 141 57 0 161 28 80 22 214 257
2022/20232.614 186 93 170 65 147 244 55 134 1.377 34 77 32
2023/2024763 54 62 76 14 138 0 136 11 9 4 132 127
2024/20251.763 17 53 99 42 74 188 197 98 389 210 83 313
2025/20266.551 372 318 589 1.103 594 485 1.021 1.215 505 349 0 0
Totale 17.002